Pyridam Farma Tbk Market Cap ($93.50 Million)
Market Cap & Net Worth: Pyridam Farma Tbk (PYFA)
Pyridam Farma Tbk market cap. Pyridam Farma Tbk (JK:PYFA) has a market capitalization of $93.50 Million (Rp1.60 Trillion) as of October 30, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #19313 globally and #317 in its home market, demonstrating a -19.32% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pyridam Farma Tbk's stock price Rp142.00 by its total outstanding shares 11236692042 (11.24 Billion).
Pyridam Farma Tbk Market Cap History (2015–2026)
Pyridam Farma Tbk market cap history from 2015 to 2026. Data shows growth from $71.19 Million to $93.50 Million (2.58% CAGR). Check PYFA share price today for real-time trading data and today's change.
Index Memberships
Pyridam Farma Tbk is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Jakarta Stock Exchange Composite Index
JKSE
|
$415.30 Billion | 0.02% | #308 of 864 |
Weight: Pyridam Farma Tbk's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Pyridam Farma Tbk Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pyridam Farma Tbk's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see cash efficiency ratio of Pyridam Farma Tbk for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.00x
Pyridam Farma Tbk's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $71.19 Million | $217.84 Billion | $3.09 Billion | 0.00x | 0.02x |
| 2016 | $127.13 Million | $216.95 Billion | $5.15 Billion | 0.00x | 0.02x |
| 2017 | $117.96 Million | $223.00 Billion | $7.13 Billion | 0.00x | 0.02x |
| 2018 | $121.82 Million | $250.45 Billion | $8.45 Billion | 0.00x | 0.01x |
| 2019 | $130.37 Million | $247.11 Billion | $9.34 Billion | 0.00x | 0.01x |
| 2020 | $641.96 Million | $277.40 Billion | $22.10 Billion | 0.00x | 0.03x |
| 2021 | $668.30 Million | $630.53 Billion | $5.48 Billion | 0.00x | 0.12x |
| 2022 | $569.54 Million | $715.43 Billion | $275.24 Billion | 0.00x | 0.00x |
| 2023 | $753.90 Million | $702.07 Billion | -$85.22 Billion | 0.00x | N/A |
| 2024 | $138.27 Million | $1.92 Trillion | -$330.25 Billion | 0.00x | N/A |
Competitor Companies of PYFA by Market Capitalization
Companies near Pyridam Farma Tbk in the global market cap rankings as of October 30, 2026. See Pyridam Farma Tbk net asset quality index to understand what proportion of total assets are financed by equity.
Key companies related to Pyridam Farma Tbk by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #515 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #536 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #600 globally with a market cap of $45.38 Billion USD ( CN¥310.15 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #626 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #515 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #536 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.98 |
| #600 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.38 Billion | CN¥48.62 |
| #626 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €17.90 |
Market Capitalization of Pyridam Farma Tbk (2015–2026)
Market capitalization of Pyridam Farma Tbk from 2015 to today. Between 2015 and today, Pyridam Farma Tbk's market cap moved from $71.19 Million to $ 93.50 Million, with a yearly change of 2.58%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp93.50 Million | -70.17% |
| 2025 | Rp313.41 Million | +126.67% |
| 2024 | Rp138.27 Million | -81.66% |
| 2023 | Rp753.90 Million | +32.37% |
| 2022 | Rp569.54 Million | -14.78% |
| 2021 | Rp668.30 Million | +4.10% |
| 2020 | Rp641.96 Million | +392.42% |
| 2019 | Rp130.37 Million | +7.01% |
| 2018 | Rp121.82 Million | +3.28% |
| 2017 | Rp117.96 Million | -7.22% |
| 2016 | Rp127.13 Million | +78.57% |
| 2015 | Rp71.19 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 30th, 2026 the market cap of Pyridam Farma Tbk was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $93.50 Million USD |
| MoneyControl | $93.50 Million USD |
| MarketWatch | $93.50 Million USD |
| marketcap.company | $93.50 Million USD |
| Reuters | $93.50 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Pyridam Farma Tbk
PT Pyridam Farma Tbk engages in the development, production, and trading of pharmaceuticals primarily in Indonesia. The company operates through Pharmaceutical Products, Esthetic, and Toll Manufacturing Services; and Medical Equipments segments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR - extra… Read more